LFB Biomedicaments Received Additional Regulatory Approval in 15 European Countries for Its World Wide Unique Von Willebrand Factor with Low Factor VIII Content: Willfact(R)

LES ULIS, France--(BUSINESS WIRE)--LFB received from the German regulatory authority (Paul-Ehrlich-Institute) a positive review feedback for the closing of the Mutual Recognition Procedure (MRP) of Willfact® 1000 IU with Germany as the reference member state.